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Abstract
Elevated birth weight is linked to glucose intolerance and obesity health-related complications 
later in life. No studies have examined if infant birth weight is associated with gene expression 
markers of obesity and inflammation in a tissue that comes directly from the infant following 
birth. We evaluated the association between birth weight and gene expression on fetal 
programming of obesity. Foreskin samples were collected following circumcision, and gene 
expression analyzed comparing the 15% greatest birth weight infants (n = 7) versus the remainder 
of the cohort (n = 40). Multivariate linear regression models were fit to relate expression levels on 
differentially expressed genes to birth weight group with adjustment for variables selected from a 
list of maternal and infant characteristics. Glucose transporter type 4 (GLUT4), insulin receptor 
substrate 2 (IRS2), leptin receptor (LEPR), lipoprotein lipase (LPL), low density lipoprotein 
receptor-related protein 1 (LRP1), matrix metalloproteinase 2 (MMP2), plasminogen activator 
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inhibitor-1 (PAI-1), and transcription factor 7-like 2 (TCF7L2) were significantly upregulated and 
histone deacetylase 1 (HDAC1) and thioredoxin (TXN) downregulated in the larger birth weight 
neonates versus controls. Multivariate modeling revealed that the estimated adjusted birth weight 
group difference exceeded one standard deviation of the expression level for eight of the 10 genes. 
Between 25% and 50% of variation in expression level was explained by multivariate modeling for 
eight of the 10 genes. Gene expression related to glycemic control, appetite/energy balance, 
obesity, and inflammation were altered in tissue from babies with elevated birth weight, and these 
genes may provide important information regarding fetal programming in macrosomic babies.
Keywords
Circumcision; fetal macrosomia; fetal programming; gestational weight gain
INTRODUCTION
Obesity has long-term, remarkable medical and public health implications.1 Obese women 
are more likely to deliver macrosomic infants.2, 3 Excessive weight gain in pregnancy also 
increases the risk for birth weight greater than the 90th percentile.4 Higher birth weights are 
associated with increased risk of adolescent obesity.5 An intergenerational risk of obesity 
and diabetes has been described, whereby maternal obesity is an independent risk factor for 
offspring obesity, separate from that of diabetes.6–9 The influences of fetal programming 
imposed by maternal obesity and diabetes may not be immediately evident at birth or early 
childhood, but may emerge later.10
The model of fetal programming outlined by David Barker classically describes the risk of 
disease among growth restricted infants during pregnancy.11 This hypothesis suggests fetal 
programming occurs based on maternal exposures which alters development and influences 
risk of future disease.11 An abnormal metabolic environment imposed by obesity or excess 
weight gain in pregnancy leads to fetal and neonatal overgrowth, childhood obesity and 
decreased insulin sensitivity.12, 13 These sequelae can lead to early onset of adult disease 
such as type 2 diabetes and metabolic syndrome. The cycle may continue when these 
women become pregnant.14 Several studies indicate that metabolic changes can be passed to 
subsequent generations. Responsible molecular mechanisms that contribute to offspring 
programming of obesity and type 2 diabetes include: hyperglycemia, impaired insulin 
signaling, increased circulation of adipocyte and inflammation signaling markers, abnormal 
adipose differentiation and metabolism, excessive placental hormone production, and 
alterations in the adipo-insular axis.15−17 Numerous studies have identified correlations 
between maternal factors and biochemical evidence of abnormal placental and fetal 
metabolism.18–22 In addition, animal models have tested the effects of under and over-
nutrition in pregnancy and its effects on offspring.23, 24
We proposed to utilize neonatal foreskin to evaluate the effects of infant birth weight on fetal 
programming. Neonatal foreskin is a tissue that is readily available where circumcisions are 
performed and has previously been utilized to assess different cellular processes including 
wound healing and developmental abnormalities such as hypospadias.25–28 Importantly, the 
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foreskin represents a terminal neonatal tissue which can be utilized in the study of 
developmental programming.29 We postulated that changes in gene expression involved in 
glucose metabolism, insulin signaling, inflammation, and oxidative stress in neonatal 
foreskin are associated with infant birth weight.
MATERIALS AND METHODS
Subjects
This was a birth cohort study of male neonates from 55 mother-baby couplets that was 
approved by the University of Kentucky Institutional Review Board. Subjects were born at 
the University of Kentucky from June 2012 to March 2013. Inclusion criteria were English-
speaking mothers, ≥ 18 years old, and term delivery (≥ 37 weeks) of a non-anomalous, 
singleton male infant. Neonates admitted to the neonatal intensive-care unit were excluded. 
Mothers who had already consented to have a circumcision performed were approached for 
study enrollment. Foreskin samples were collected by study personnel after routine 
circumcisions were performed by the obstetric team on duty each day. The hypodermis 
(dartos) layer was immediately, grossly dissected from the dermis/epidermis. Samples were 
frozen in liquid nitrogen and stored at −80°C until processing. Eight samples were excluded 
because they were twins (n = 4) or preterm (n = 2), so tissues were not analyzed, or the RNA 
was degraded (n = 2).
Data Collection
Maternal demographic and clinical factors [pre-pregnancy body mass index (BMI), 
gestational weight gain, co-morbidities, and delivery data] and infant birth weight and 
anthropomorphic measurements (body length and head circumference) were recorded. 
Maternal ethnicity and smoking status were self-reported.
Sample Processing
mRNA Isolation.—Approximately 40 mg of tissue was placed in 1 mL Qiazol and 
homogenized using a Geno/Grinder 2010 (SPEX SamplePrep). RNA was extracted from 
hypodermis samples using the Qiagen RNeasy Lipid Tissue Mini Kit (Cat. No. 74804, 
Qiagen).30 RNA was eluted from column using 30 µl of nuclease free water. RNA integrity 
number (RIN) was measured using an Agilent 2100 BioAnalyzer (Agilent) and samples with 
RIN values lower than 6.8 were omitted (2 samples). The average RIN for the remaining 47 
hypodermis samples was 8.3. cDNA was reverse transcribed using C1000 Thermal Cycler 
(Bio-Rad Laboratories, Inc.) and qScript cDNA SuperMix (Quanta Biosciences) for 
quantitative real-time PCR (qPCR).
NanoString CodeSet.—We pre-selected a panel of 120 genes involved in glucose 
metabolism, insulin signaling, inflammation, and oxidative stress. One hundred ng of RNA 
was loaded per sample for each NanoString run. NanoString results were normalized by 
creating scaling factors for positive controls (sum of positive controls) and pre-selected 
housekeeping genes (the geometric mean was calculated for 13 housekeeping genes for each 
sample) according to manufacturer’s suggestions. After normalization, all 13 housekeeping 
genes had a false discovery rate (FDR)-adjusted p-values above 0.10 in comparing the 7 
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largest babies to the other 40.31, 32 The FDR was defined with respect to these 13 genes. 
There were 17 (non-housekeeping) genes whose average corrected NanoString counts were 
below 15; these were excluded from the analyses described subsequently. A comprehensive 
list of analyzed genes is included (Supplemental Information). The NanoString nCounter 
system is highly reproducible and provides similar expression patterns to qPCR.33
qPCR.—Quantitative PCR was performed using a Step One Plus Real-Time PCR System 
(Applied Biosystems, Life Technologies). 20 ng cDNA/reaction was used in conjunction 
with TaqMan probes (Applied Biosystems, Life Technologies) developed using gene 
accession numbers associated with NanoString CodeSet above. Tubulin, beta class I (TUBB, 
Cat. # Hs00742828_s1) was selected as an endogenous control for normalization due to its 
expression levels being comparable for the two groups of babies. The top three genes from 
Table 2, plasminogen activator inhibitor 1 (PAI-1, Hs01126606_m1), glucose transporter 
type 4 (GLUT4, Hs00168966_m1), leptin receptor (LEPR, HS00174497_m1) were 
validated with qPCR for a subset of the samples. A subset of the control samples (n=7) were 
tissues collected from babies directly before or after the increased birth weight babies (n=7). 
Genes of interest were run in duplicate and TUBB was run in triplicate. Replicates were then 
averaged, and mRNA expression levels are presented as 2ΔΔCT. 34
Statistical Analysis
Statistical analyses were done using Sigma Plot 12.0 (Jandel Scientific, Chicago, IL), SAS 
9.3 (SAS Institute Inc, Cary, NC), and Microsoft Excel 2013 (Microsoft Corp., Redmond 
WA). As this was a pilot and exploratory study, an a priori power analysis was not 
conducted. We targeted a sample size of 50. Greater birth weight was defined as the top 15% 
of the cohort (7 babies), and the control group consisted of the remainder of the samples (40 
babies). In bivariate analysis (Table 1), we compared the two groups on continuous clinical 
factors via t-tests and on categorical clinical factors via Fisher’s exact tests. NanoString gene 
expression was analyzed via t-test according to birth weight stratum. If expression departed 
substantially from normality, a log transformation was performed before t-test; this 
happened once (nicotinamide phosphoribosyltransferase). If even log-transformed 
expression departed substantially from normality, a nonparametric rank sum test was 
performed in lieu of t-test; this happened once (superoxide dismutase 1). Group variances 
were treated as equal in the t-test unless a companion f-test yielded a contrary result (with P 
< 0.01), which happened three times [histone deacetylase 1 (HDAC1), low density 
lipoprotein receptor-related protein 1 (LRP1), and thioredoxin (TXN)]. The 90 resulting p-
values (120 minus 13 [housekeeping] minus 17 [low counts]) were adjusted by FDR.31, 32 
The 10 genes with FDR-adjusted P < 0.05 were ranked by fold change (Mean increased 
birth weight group/Mean control). In multivariate analysis on the 10 genes for which FDR-
adjusted p-values were less than 0.05, the Schwarz Bayesian Criterion35 was used to select a 
multiple linear regression model predicting expression for each gene based on group 
membership (increased birth weight versus not) and a subset of variables chosen from the 
following list: ethnicity of the mother (Caucasian versus not), gestational weight gain 
category (over recommended versus not), mode of delivery (caesarean versus not), smoking 
during pregnancy (yes versus no), insurance status (private versus not), employment (full-
time versus not), education (affirmed college degree or better versus not), feeding (complete 
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or partial use of bottle versus not), third trimester glucose tolerance test, ponderal index, age 
at delivery, gravida, parity, pre-pregnancy weight, pre-pregnancy BMI, gestational weight 
gain, gestational age, day of life for circumcision, birth weight, birth length, and head 
circumference. Ten records (out of 47) had missing values on glucose tolerance test or 
ponderal index, which were imputed by mean value within birth weight group. Ordinary 
least squares was used for model fitting, unless birth weight group variances were 
substantially different (as judged by the aforementioned f-test), in which case weighted least 
squares was employed. qPCR gene expression was compared between birth weight groups 
by t-test and natural log transformation performed preceding t-test when normality failed 
(PAI-1 and GLUT4). Continuous data are summarized as mean ± SEM and categorical data 
by counts.
RESULTS
Maternal:
Table 1 outlines the demographics and obstetrical characteristics of our study sample. The 
mean maternal age was 27.6 years (range 20–38). Thirty-two percent of women smoked 
prior to pregnancy (15/47); no mother’s smoking status changed during pregnancy. The 
mean parity was 2.0 (range 1–5). The mean gestational age at delivery was 39.3 weeks 
(range from 37.2–41.3). Sixty-two percent of the study patients delivered vaginally. The 
mean pre-pregnancy BMI in our study cohort was 26.0 kg/m22 (range 17.5–41.4). Twenty-
seven percent of women were categorized as obese with BMI > 30 and mean gestational 
weight gain was 14.5 kg (range 3.2–26.3). 43% (20/47) of women gained excess weight 
during pregnancy, 47% (22/47) gained within the recommendations, and 11% (5/47) gained 
less than recommended.36 Overall, gestational weight gain was similar between obese and 
non-obese women (P = 0.77). The mean 3rd trimester 50 g glucose challenge was 113.8 
mg/dl (range 64–179) and was not significantly correlated with continuous birth weight in 
this cohort, (P = 0.74). Ten women underwent 3 hour glucose challenge for screening values 
>130 mg/dl and one was diagnosed with gestational diabetes. Six women were diagnosed 
with gestational hypertension, and three developed pre-eclampsia.
Offspring:
Foreskin samples from 47 neonates were used for NanoString analysis. About half of the 
samples were taken on day 1 of life (51%, range 0–3). The mean birth weight of the control 
babies was 3324 ± 60 grams compared to 4115 ± 87 grams for the top 15% of babies in the 
cohort (P < 0.0001).
The control and increased birth weight samples did not differ significantly according to 
maternal age (P = 0.84), ethnicity (P = 0.49), parity (P = 0.68), smoking (P = 1.00), or mode 
of delivery (P = 1.00). In this cohort, pre-pregnancy BMI was not significantly correlated 
with continuous birth weight overall (P = 0.36), and birth weights were not significantly 
different between non-obese and obese mothers (3411 ± 80 g vs. 3521 ± 120 g, P = 0.47). 
Gestational weight gain was significantly correlated with continuous birth weight (Pearson’s 
r = 0.43; P = 0.002) and women that gave birth to increased birth weight babies also had 
higher gestational weight gain (P = 0.01; Table 1).
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Gene expression was measured in the hypodermis of 47 neonates and expression levels of 
the highest 15% of birth weight babies (n = 7) were compared to those of the remaining 
babies (n = 40). Table 2 shows the 10 genes with an FDR adjusted P < 0.05. Both HDAC1 
and TXN were significantly downregulated in the hypodermal layer in higher birth weight 
newborns compared to the remainder of the cohort. Eight genes were significantly 
upregulated with a fold change > 1.25 in the larger babies. These genes were PAI-1, GLUT4, 
LEPR, lipoprotein lipase (LPL), matrix metalloproteinase 2 (MMP2), insulin receptor 
substrate 2 (IRS2), LRP1, and transcription factor 7-like 2 (TCF7L2). We validated 3 genes 
with the greatest (and significantly different) fold change in mRNA differences in the 
NanoString CodeSet with real-time PCR (PAI-1, GLUT4, and LEPR). We found significant 
increases in PAI-1 (P = 0.006), GLUT4 (P = 0.026), and LEPR (P = 0.043) in babies with 
the 15% highest birth weights compared to a subset (n = 7) of the normal weight babies 
(Figure 1).
Multivariate analysis results are summarized in Table 3. Each column represents a different 
regression model, corresponding to one of the 10 genes for which the FDR-adjusted p-value 
was less than 0.05 in comparing birth weight groups. Eight of the 10 models contain, in 
addition to group, one or more maternal or infant characteristics which portend gene 
expression. As an example, controlling for gestational age, LEPR expression is predicted to 
increase by more than one-and-a-half of its standard deviations when birth weight crosses 
from normal to elevated; and, controlling for birth weight, each increase in gestational age 
by one of its standard deviations decreases predicted LEPR expression by approximately 
one-quarter of its standard deviation. The latter result makes sense intuitively; for instance, if 
a 37-week gestational age baby and a 41-week gestational age baby have the same birth 
weight, then the 37-week baby is larger relative to his age and would be anticipated to have 
greater LEPR expression consistent with being of larger size. With two exceptions, one on 
the high end (PAI-1, 65.9%) and one on the low end (TCF7L2, 16.1%) between 25% and 
50% of each gene’s variation in expression level was accounted for by birth weight group 
and other maternal or infant characteristics. Besides birth weight, the predictor most often 
appearing in multivariate analysis was gravida, which was selected for five out of the 10 
regression models. The direction of the relationship between gravida and gene expression in 
these five models was the same as that between birth weight and gene expression; when 
increased birth weight corresponded to greater gene expression, so did increased gravida, 
and vice versa. In addition, part or all bottle fed appeared in four out of the ten regression 
models with the direction of the relationship being opposite to that of birthweight and gene 
expression. No other predictor was selected for more than two of the regression models, 
though, interestingly, the model for PAI-1 contained 10 predictors; no other model contained 
as many as five.
DISCUSSION
We used human foreskin tissue to assess changes in gene expression of neonates related to 
obesity, weight gain in pregnancy, and birth weight. Our main finding was that birth weight 
was associated with the expression of genes related to metabolism and inflammation in 
neonatal tissue. We confirmed what others have shown37 in that birth weight was positively 
correlated with gestational weight gain. Understanding weight induced alterations in gene 
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expression may be important in establishing potential mechanisms responsible for the 
detrimental effects of small or large birth weight and increased maternal weight gain on 
offspring risk of developing obesity and type 2 diabetes. While we do not anticipate that 
gene expression changes in the foreskin are driving whole body changes in appetite and 
energy balance, hyperglycemia, and inflammation, we suspect that these changes are 
representative of the types of alterations that are seen in other tissues. Results from this 
study point to the foreskin as a useful model to study developmental programming using a 
tissue that comes directly from the infant after birth and may not include maternal 
contributions like placenta38 and cord blood.39 However, given that others have shown that 
elevated baby birth weight impacts a number of markers related to glycemic control,40 
appetite/energy balance,41, 42 obesity,43 and inflammation in placenta or cord blood,18 we 
assessed similar markers in the neonatal foreskin.
Upregulation of gene expression in foreskin tissue related to appetite and energy balance, 
hyperglycemia, and inflammation were found in babies with increased birth weight. These 
data support human epidemiological evidence demonstrating that high birth weight babies 
are at an increased risk for developing obesity44, 45 and type 2 diabetes later in life46. These 
data further our knowledge by providing mechanisms of dysfunction that may be 
predisposing high birth weight babies to an obese, insulin resistant phenotype at increased 
risk of developing cardiovascular disease in adulthood. 47 Several markers of obesity, insulin 
resistance, and cardiovascular disease had the greatest fold change in gene expression with 
higher birth weight (Table 2). While some markers have been measured in animal models of 
developmental programming or in human placenta/cord blood, this is the first study to 
examine them in neonatal foreskin. The skin is readily available following circumcision at 
birth and can be obtained later in life through skin biopsies. These repeated measures are a 
necessary next step in determining if the observed gene expression changes in the current 
study extend beyond infancy.
Results from the present study suggest that high birth weight babies have increased 
expression of obesity related genes (LPL and LEPR). Studies in rodents have shown that 
treating hyperleptinemia in offspring late in development slows neonatal weight gain and 
reverses prenatal adaptations resulting from stimuli that promote adulthood obesity.48 LEPR 
expression is increased in response to leptin insensitivity as a compensatory mechanism to 
defend against obesity. However, in later stages of LEPR insensitivity, there is a loss of 
weight homeostasis and obesity ensues 48 This provides exciting evidence of particular 
markers which may be targeted for therapeutic interventions in high birth weight babies to 
prevent adulthood obesity. Future studies in our lab will begin to investigate these 
mechanisms in humans.
Chronic obesity leads to whole body and skeletal muscle insulin resistance.49 A number of 
proteins are involved in regulating cellular insulin sensitivity. GLUT4 mRNA is increased 
acutely in response to hyperinsulinemia;50 however, as insulin resistance develops and 
progresses to type 2 diabetes, translocation of GLUT4 to the cell membrane in response to 
insulin is reduced.51 While infants in the present study were not obese per se, we did find 
that the highest 15% body weight babies had significantly elevated mRNA expression of 
GLUT4 and IRS2, proteins stimulated by insulin which are, in part, responsible for glucose 
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uptake into cells. Though, it is important to note that we did not directly measure differences 
in protein or phosphorylation levels as part of this study.
In the area of developmental programming, elevated levels of PAI-1, an inhibitor of 
fibrinolysis, were found in the white adipose tissue of male rat offspring born to obese dams 
fed a high-fat diet during pregnancy.52 This is a phenotype that is common in obesity and is 
related to increased risk of developing cardiovascular disease.53 In the heart, elevated PAI-1 
plays a role in the development of fibrosis.54 In the present study, PAI-1 was increased in the 
hypodermal layer of the foreskin in the 15% highest birth weight babies; however, whether 
or not this also translates into increased PAI-1 expression in the hearts of these babies which 
might be predisposing them to greater risk of developing cardiovascular disease is not 
known. Huang et al. demonstrated that fetal hearts of sheep from obese mothers had 
increased cardiac fibrosis,55 thus, this may be a mechanism of increased cardiovascular 
disease risk in babies born to obese mothers (and thus, predisposed to elevated birth weight).
56
 Interestingly, TXN, an antioxidant,57 was reduced in the 15% highest birth weight babies, 
thus providing further evidence for a phenotype which may be more predisposed to 
increased oxidative stress and developing cardiovascular disease later in life. In fact, 
previous animal studies have demonstrated that offspring born to obese dams tend to have 
higher rates of oxidative stress,58 potentially due to downregulation of TXN.
Although not a specific aim of the paper, it is of interest that gravida, or number of 
pregnancies a woman has had, appeared as a predictor in five of the regression models 
(Table 3), second in frequency to increased birth weight. Increased parity, or number of live 
births a female has had (which would also increase gravida), has been associated with 
weight gain and obesity in humans59 and mice.60 Given that obese mothers tend to have 
bigger babies,61 the fact that all of the genes whose expression levels were altered with 
gravida (adjusted for other variables) are also associated in the same direction with increased 
birth weight, is not a surprise.
There were several limitations to this study. The top 15% birth weight babies were grouped 
together, as opposed to using a more standard definition of macrosomia, due to our limited 
sample size. Further, the relatively low number of samples did not allow for analysis of 
gestational diabetes or hypertension as confounding factors on gene expression. While gene 
expression was altered in the top 15% birth weight babies compared to controls, it is 
significant to note that mRNA levels do not strongly correlate with protein expression.62 
Finally, neonatal tissue can only be collected in males following circumcision; thus, female 
neonates were not included in this study and we cannot comment on a potential sex bias at 
this time. Despite these limitations, we have demonstrated the neonatal foreskin as a useful 
tissue to study developmental programming.
We found that gene expression related to glycemic control, appetite/energy balance, obesity, 
and inflammation was altered in tissue from babies with elevated birth weight. These genes 
point to potential mechanisms regarding fetal programming in macrosomic babies. 
Importantly, this model can be expanded in future studies to include collection of placenta, 
cord blood, and maternal serum for comparative analyses.
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Figure 1. 
qPCR validation of 3 genes with the highest (and significant) fold change in mRNA 
differences in the NanoString CodeSet. Horizontal line depicts the mean expression for each 
gene.
REYNOLDS et al. Page 13
J Dev Orig Health Dis. Author manuscript; available in PMC 2018 December 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
REYNOLDS et al. Page 14
Table 1.
Maternal Demographics of Study Sample
Maternal Variable
Total Sample
(n = 47)
Control
(n = 40)
Increased Birth Weight
(n = 7) P a
Ethnicity b 0.49
Non-Hispanic White 32 27 5
Non-Hispanic Black 12 11 1
Hispanic 1 1 0
Asian 2 1 1
Smoker b 15 13 2 1.00
Parity c 2.0 ± 0.2 2.1 ± 0.2 1.9 ± 0.3 0.68
GA at Delivery, Weeks c 39.3 ± 0.1 39.3 ± 0.2 39.2 ± 0.4 0.79
Mode of Delivery b 1.00
SVD 29 25 4
CS 18 15 3
Pre-Pregnancy BMI c 26.0 ± 1.0 25.5 ± 1.0 28.9 ± 3.6 0.21
Gestational Weight Gain, kg c 14.5 ± 0.8 13.7 ± 0.8 19.2 ± 1.9 0.01
Gestational Weight Gain, Category b 0.33
under 5 5 0
normal 22 20 2
over 20 15 5
3rd Trimester Glucola c,d 113.8 ± 4.0 111.0 ± 4.2 128.0 ± 10.8 0.12
Abbreviations: BMI (body mass index), CS (caesarean section), GA (gestational age), SVD (spontaneous vaginal delivery)
aContinuous variables were compared with the use of Student t-test while categorical variables were compared by Fisher’s exact test;
b
Data given as count;
c
Data are given as mean ± SEM;
dGlucose tolerance test (Glucola).
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Table 2.
Comparison of gene expression in hypodermis in the subsample with higher birth weight versus control
Gene
Average Gene
Expression
Control a
Average Gene
Expression
Increased Birth
Weight b
Fold
Change c
Unadjusted
P value d
FDR
Adjusted
P Value e
PAI-1 20.4 ± 1.8 66.6 ± 31.7 3.27 0.0011 0.0198
GLUT4 27.6 ± 1.6 50.2 ± 7.9 1.82 <0.0001 0.0022
LEPR 83.3 ± 3.8 145.6 ± 21.8 1.75 <0.0001 0.0010
LPL 15.3 ± 0.9 24.6 ± 5.4 1.61 0.0038 0.0429
MMP2 348.8 ± 22.3 558.9 ± 74.6 1.60 0.0013 0.0198
IRS2 50.8 ± 2.3 75.9 ± 10.7 1.50 0.0007 0.0159
LRP1 318.1 ± 10.0 443.8 ± 29.5 1.39 0.0044 0.0439
TCF7L2 156.1 ± 5.9 201.6 ± 15.7 1.29 0.0053 0.0474
HDAC1 434.5 ± 9.6 344.7 ± 15.4 0.79 0.0004 0.0120
TXN 3095.9 ± 144.8 2221.7 ± 178.6 0.72 0.0017 0.0213
a
Data are given as mean ± SEM,
b
Increased birth weight group is the top 15 percent from the study (n = 7) compared to the rest (n = 40),
c
Fold change in mean gene expression of increased birth weight divided by control,
dUnadjusted p-values from t-tests are shown.
e
False discovery rate-adjusted p-values are displayed; since this table includes only genes with FDR-adjusted p-values below 0.05, the 
interpretation is that we expect 9 or 10 of these discoveries to be true.
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Table 3.
Multivariate Analysis of Gene Expression Levels
Predictor/
Outcome
GLUT4 HDAC1* IRS2 LEPR LPL LRP1* MMP2 PAI-1 TCF7L2 TXN*
Increased Birth Weight 1.60
p<0.001
−1.41
p<0.001
1.16
p=0.002
1.62
p<0.001
1.22
p=0.001
1.59
p<0.001
1.31
p<0.001
0.90
p=0.007
1.11
p=0.005
−0.86
p<0.001
Gravida 0.29
p=0.019
−0.29
p=0.016
0.35
p=0.010
0.26
p=0.054
−0.34
p=0.008
Part or All Bottle −0.53
p=0.048
−0.68
p=0.018
−0.74
p=0.005
0.66
p=0.007
Glucose Tolerance Test 0.28
p=0.029
0.29
p=0.008
Gestational Age −0.26
p=0.028
−0.27
p=0.018
Affirmed College Degree 
or Better
−0.62
p=0.032
−0.85
p=0.003
Gestational Weight Gain 
Over Recommended
0.62
p=0.008
Smoke During Pregnancy 0.63
p=0.018
Private Insurance 1.22
p=0.002
Full-Time Employment −0.90
p=0.010
Day of Life 
Circumcision
−0.21
p=0.065
Ponderal Index −0.26
p=0.030
R2 0.391 0.434 0.403 0.420 0.299 0.266 0.272 0.659 0.161 0.455
Each column represents a separate regression model. Variables actually selected for each model are those whose cell entries are filled in. Each 
regression coefficient is the estimated number of standard deviations by which the outcome is expected to increase when the predictor goes from no 
to yes (if the predictor is binary) or when the predictor increases by one standard deviation (if the predictor is continuous), while adjusting for all 
other predictors in the same model; these regression coefficients turned out to be greater than 0.50 in absolute value for all binary predictors and 
less than 0.50 in absolute value for all continuous predictors. Accompanying each regression coefficient is a p-value. Asterisks in column headings 
indicate a weighted least squares analysis. The final row contains R2, the proportion of (weighted) variation in gene expression explained by the 
variables used to predict it.
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